phosphatidylcholines has been researched along with Entomophthoramycosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perfect, JR | 2 |
| Alexander, D; Crompton, JA; Shihab, FS; Somerville, T | 1 |
| Chandrasekar, P | 1 |
| Forrest, GN; Mankes, K | 1 |
| Bandettini, R; Di Marco, E; Mantero, E; Tamisani, AM; Tuo, P | 1 |
| Edwards, JE; Fu, Y; Gebremariam, T; Husseiny, MI; Ibrahim, AS; Spellberg, B; Stevens, DA | 1 |
| Arndt, C; Chanock, SJ; Dinubile, MJ; Harris, RE; Hiemenz, J; Reboli, A; Seibel, NL; Walsh, TJ | 1 |
1 review(s) available for phosphatidylcholines and Entomophthoramycosis
| Article | Year |
|---|---|
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
1 trial(s) available for phosphatidylcholines and Entomophthoramycosis
| Article | Year |
|---|---|
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis | 1999 |
6 other study(ies) available for phosphatidylcholines and Entomophthoramycosis
| Article | Year |
|---|---|
Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
Topics: Amphotericin B; Antifungal Agents; Creatinine; Drug Combinations; Humans; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis | 2004 |
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Fusarium; Humans; Immunocompromised Host; Infant; Kidney; Male; Middle Aged; Mycoses; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Retrospective Studies; Treatment Outcome; Zygomycosis | 2005 |
The experience is CLEAR.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cryptococcosis; Databases, Factual; Drug Combinations; Humans; In Vitro Techniques; Multicenter Studies as Topic; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prospective Studies; Treatment Outcome; Zygomycosis | 2006 |
Outcomes of invasive zygomycosis infections in renal transplant recipients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Transplantation; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Risk Factors; Zygomycosis | 2007 |
Severe cutaneous zygomycosis: evaluation of treatment with high doses of liposomal amphotericin B in a one-year old child.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Combinations; Humans; Immunocompromised Host; Infant; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis | 2007 |
Comparison of lipid amphotericin B preparations in treating murine zygomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Diabetic Ketoacidosis; Disease Models, Animal; Drug Combinations; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Rhizopus; Treatment Outcome; Zygomycosis | 2008 |